Literature DB >> 18977698

Oligoclonal myelin-reactive T-cell infiltrates derived from multiple sclerosis lesions are enriched in Th17 cells.

Monica Montes1, Xin Zhang, Laureline Berthelot, David-Axel Laplaud, Sophie Brouard, Jianping Jin, Sarah Rogan, Diane Armao, Valerie Jewells, Jean-Paul Soulillou, Silva Markovic-Plese.   

Abstract

In this study, acute and chronic brain and spinal cord lesions, and normal appearing white matter (NAWM), were resected post-mortem from a patient with aggressive relapsing-remitting multiple sclerosis (MS). T-cell infiltrates from the central nervous system (CNS) lesions and NAWM were separated and characterized in-vitro. All infiltrates showed a proliferative response against multiple myelin peptides. Studies of the T-cell receptor (TCR)Vbeta and Jbeta usage revealed a very skewed repertoire with shared complementarity-determining region (CDR)3 lengths detected in all CNS lesions and NAWM. In the acute lesion, genomic profiling of the infiltrating T-cells revealed up-regulated expression of TCRalpha and beta chain, retinoic acid-related orphan nuclear hormone receptor C (RORC) transcription factor, and multiple cytokine genes that mediate Th17 cell expansion. The differentially expressed genes involved in regulation of Th17 cells represent promising targets for new therapies of relapsing-remitting MS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18977698      PMCID: PMC6961709          DOI: 10.1016/j.clim.2008.08.030

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  32 in total

1.  Antigen-independent in vitro expansion of T cells does not affect the T cell receptor V beta repertoire.

Authors:  M Arenz; S Herzog-Hauff; K H Meyer zum Büschenfelde; H F Löhr
Journal:  J Mol Med (Berl)       Date:  1997-09       Impact factor: 4.599

2.  Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis.

Authors:  B A C Cree; O Khan; D Bourdette; D S Goodin; J A Cohen; R A Marrie; D Glidden; B Weinstock-Guttman; D Reich; N Patterson; J L Haines; M Pericak-Vance; C DeLoa; J R Oksenberg; S L Hauser
Journal:  Neurology       Date:  2004-12-14       Impact factor: 9.910

Review 3.  Immunology of multiple sclerosis.

Authors:  Mireia Sospedra; Roland Martin
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

4.  High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism.

Authors:  M Ziolkowska; A Koc; G Luszczykiewicz; K Ksiezopolska-Pietrzak; E Klimczak; H Chwalinska-Sadowska; W Maslinski
Journal:  J Immunol       Date:  2000-03-01       Impact factor: 5.422

5.  Revised diagnostic criteria for neuromyelitis optica.

Authors:  D M Wingerchuk; V A Lennon; S J Pittock; C F Lucchinetti; B G Weinshenker
Journal:  Neurology       Date:  2006-05-23       Impact factor: 9.910

6.  Cyclosporine A inhibits IL-15-induced IL-17 production in CD4+ T cells via down-regulation of PI3K/Akt and NF-kappaB.

Authors:  Mi-La Cho; Ji Hyeon Ju; Kyoung-Woon Kim; Young-Mee Moon; Seon-Yeong Lee; So-Youn Min; Young-Gyu Cho; Hyun-Sook Kim; Kyung-Su Park; Chong-Hyeon Yoon; Sang Heon Lee; Sung-Hwan Park; Ho-Youn Kim
Journal:  Immunol Lett       Date:  2006-11-27       Impact factor: 3.685

7.  Multiple sclerosis: T-cell receptor expression in distinct brain regions.

Authors:  Andreas Junker; Jana Ivanidze; Joachim Malotka; Ingrid Eiglmeier; Hans Lassmann; Hartmut Wekerle; Edgar Meinl; Reinhard Hohlfeld; Klaus Dornmair
Journal:  Brain       Date:  2007-09-21       Impact factor: 13.501

8.  Risk alleles for multiple sclerosis identified by a genomewide study.

Authors:  David A Hafler; Alastair Compston; Stephen Sawcer; Eric S Lander; Mark J Daly; Philip L De Jager; Paul I W de Bakker; Stacey B Gabriel; Daniel B Mirel; Adrian J Ivinson; Margaret A Pericak-Vance; Simon G Gregory; John D Rioux; Jacob L McCauley; Jonathan L Haines; Lisa F Barcellos; Bruce Cree; Jorge R Oksenberg; Stephen L Hauser
Journal:  N Engl J Med       Date:  2007-07-29       Impact factor: 91.245

9.  Multiple sclerosis: brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood.

Authors:  Christian Skulina; Stephan Schmidt; Klaus Dornmair; Holger Babbe; Axel Roers; Klaus Rajewsky; Hartmut Wekerle; Reinhard Hohlfeld; Norbert Goebels
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

10.  Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis.

Authors:  J Zhang; S Markovic-Plese; B Lacet; J Raus; H L Weiner; D A Hafler
Journal:  J Exp Med       Date:  1994-03-01       Impact factor: 14.307

View more
  46 in total

1.  Potential role of Th17 cells in the pathogenesis of type 2 autoimmune pancreatitis.

Authors:  M Loos; F Lauffer; A M Schlitter; J Kleeff; H Friess; G Klöppel; I Esposito
Journal:  Virchows Arch       Date:  2015-10-01       Impact factor: 4.064

2.  IL-9 is important for T-cell activation and differentiation in autoimmune inflammation of the central nervous system.

Authors:  Hongmei Li; Bardia Nourbakhsh; Melissa Cullimore; Guang-Xian Zhang; Abdolmohamad Rostami
Journal:  Eur J Immunol       Date:  2011-07-06       Impact factor: 5.532

Review 3.  Regulation of lymphocyte trafficking in central nervous system autoimmunity.

Authors:  Mohamed Oukka; Estelle Bettelli
Journal:  Curr Opin Immunol       Date:  2018-09-27       Impact factor: 7.486

4.  IL-17 enhancement of the IL-6 signaling cascade in astrocytes.

Authors:  Xiangyu Ma; Stephanie L Reynolds; Brandi J Baker; Xingang Li; Etty N Benveniste; Hongwei Qin
Journal:  J Immunol       Date:  2010-03-29       Impact factor: 5.422

Review 5.  T cells in multiple sclerosis and experimental autoimmune encephalomyelitis.

Authors:  J M Fletcher; S J Lalor; C M Sweeney; N Tubridy; K H G Mills
Journal:  Clin Exp Immunol       Date:  2010-10       Impact factor: 4.330

Review 6.  White matter damage after traumatic brain injury: A role for damage associated molecular patterns.

Authors:  Molly Braun; Kumar Vaibhav; Nancy M Saad; Sumbul Fatima; John R Vender; Babak Baban; Md Nasrul Hoda; Krishnan M Dhandapani
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-05-19       Impact factor: 5.187

Review 7.  Single nucleotide polymorphisms in multiple sclerosis: disease susceptibility and treatment response biomarkers.

Authors:  Vera Pravica; Dusan Popadic; Emina Savic; Milos Markovic; Jelena Drulovic; Marija Mostarica-Stojkovic
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

Review 8.  The pathological spectrum of CNS inflammatory demyelinating diseases.

Authors:  Wei Hu; Claudia F Lucchinetti
Journal:  Semin Immunopathol       Date:  2009-09-25       Impact factor: 9.623

9.  A transcription factor map as revealed by a genome-wide gene expression analysis of whole-blood mRNA transcriptome in multiple sclerosis.

Authors:  Carlos Riveros; Drew Mellor; Kaushal S Gandhi; Fiona C McKay; Mathew B Cox; Regina Berretta; S Yahya Vaezpour; Mario Inostroza-Ponta; Simon A Broadley; Robert N Heard; Stephen Vucic; Graeme J Stewart; David W Williams; Rodney J Scott; Jeanette Lechner-Scott; David R Booth; Pablo Moscato
Journal:  PLoS One       Date:  2010-12-01       Impact factor: 3.240

10.  The effect of vitamin A supplementation on retinoic acid-related orphan receptor γt (RORγt) and interleukin-17 (IL-17) gene expression in Avonex-treated multiple sclerotic patients.

Authors:  Niyaz Mohammadzadeh Honarvar; Mohammad Hossein Harirchian; Fariba Koohdani; Feridoun Siassi; Mina Abdolahi; Sama Bitarafan; Eisa Salehi; Mohammad Ali Sahraian; Mohammad Reza Eshraghian; Ali Akbar Saboor-Yarghi
Journal:  J Mol Neurosci       Date:  2013-07-19       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.